Cantourage UK was founded in 2021 with a clear mandate: to build the infrastructure the UK medical cannabis market was missing. Reliable supply, transparent sourcing, and clinical rigour are not differentiators for us. They are the baseline.
Since the UK legalised medical cannabis in 2018, access has remained challenging. Complex regulations, fragmented supply chains, and inconsistent product quality continue to affect pharmacies, prescribers, and patients. We exist to help change that.
As the London-based subsidiary of Cantourage SE, part of Europe’s leading publicly listed medical cannabis group, that mission is supported by a wider international platform. It gives us access to deeper supplier relationships, established import pathways, broader market intelligence, and the operational confidence needed in a fast-moving category.
Today, Cantourage UK operates as a full-stack supply partner, connecting tier-1 cultivators in Europe, Canada, and New Zealand with pharmacies and clinics across the United Kingdom.